A passionate doctor
In the origins of Singuladerm, we find the founder Doctor in Chemistry and founder of Prima-Derm with a long career in the field of research in the pharmaceutical industry, Dr. García Antón, with more than 30 years of experience in the cosmetic sector , in 2008 he founded Prima-Derm, S.L. In 2015, we obtain the medal of honor to the promotion of the invention, which the García Cabrerizo Foundation, linked to the CSIC annually.
In March 2009, Singuladerm was born, the first premium-aderm brand, for sale in pharmacies. Its formulations include the highest concentration of world reference assets and the first Botox-Like effect expression peptide: Argireline® or Snap®.
The elaboration process of each of our formulas is long and complex. It is completed with exhaustive studies of efficacy, in vitro and in vivo and test of stability, toxicity and quality until finding our secret formula that is: Effective, safe and without toxicity.
The peptides
The skin, not only separates us and protects us from the outside, also communicates with it. The beauty and health of the skin go hand in hand with the use of peptides and natural growth factors in your cosmetics. Both peptides and natural growth factors are cosmetic active ingredients that are classified as optimizers of any facial cosmetic routine.
Peptides are small chains of amino acids involved in the regulation of different metabolic processes. At the cosmetic level, peptides can:
- Modulate muscle contraction relaxing expression wrinkles
- Modulate melanin synthesis and dark pigments
- Induce the synthesis of structural components of the dermis such as collagen and elastin
Assets of natural origin
The assets we use are of natural origin, are extracted from natural habitats such as the jungle, the underwater caves of Mallorca or the island meeting in the middle of the Pacific Ocean.
In the laboratory, we ensure that these assets are at the maximum degree of concentration allowed and manage to penetrate the layer of the skin where the greatest efficiency will be achieved.
In addition, in April 2021 we will create in Spain the first laboratory capable of measuring with Franz cells the real effectiveness of the assets of our products and those of the competition.